End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.01 CNY | -2.46% | +2.04% | +4.57% |
Apr. 24 | Runben Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 1.35B 187M | Sales 2025 * | 1.72B 238M | Capitalization | 7.69B 1.06B |
---|---|---|---|---|---|
Net income 2024 * | 287M 39.73M | Net income 2025 * | 360M 49.83M | EV / Sales 2024 * | 5.71 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 4.47 x |
P/E ratio 2024 * |
26.8
x | P/E ratio 2025 * |
21.4
x | Employees | 788 |
Yield 2024 * |
1.02% | Yield 2025 * |
1.26% | Free-Float | 15.26% |
1 day | -2.46% | ||
1 week | +2.04% | ||
Current month | +2.04% | ||
1 month | +14.66% | ||
3 months | +39.37% | ||
6 months | +6.38% | ||
Current year | +4.57% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 19.01 | -2.46% | 2,247,577 |
24-05-09 | 19.49 | +0.15% | 1,640,593 |
24-05-08 | 19.46 | -0.92% | 1,991,752 |
24-05-07 | 19.64 | +0.05% | 3,685,159 |
End-of-day quote Shanghai S.E., May 09, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- 603193 Stock